Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04057066
Other study ID # ms bewegt 1.2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 28, 2019
Est. completion date August 16, 2019

Study information

Verified date April 2020
Source University of Erlangen-Nürnberg
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the feasibility of a 12-week internet-based exercise and physical activity counseling intervention for people with Multiple Sclerosis (MS).


Description:

Due to high inactivity rates in persons with Multiple Sclerosis (pwMS) physical activity promotion for this target group is needed. The internet is an attractive and feasible medium for physical activity promotion, however interventions have to be adapted to the special needs of pwMS. This study aims to evaluate the feasibility of a 12-week internet-based exercise and physical activity counseling intervention.

26 pwMS will be enrolled in the study. All of them receive the intervention. Focus groups and interviews will be conducted with participating pwMS to determine acceptability of the intervention and to explore participants experiences. Compliance with the intervention will be monitored. Additionally, changes in objective physical activity, subjective physical activity, fatigue, walking ability and level of depression will be calculated.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date August 16, 2019
Est. primary completion date August 16, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- diagnosed Multiple Sclerosis (McDonald criteria)

- expanded Disability Status Scale between 0 - 6.5

- neurologically stable (no exacerbation within 30 days prior to enrollment)

- internet access (WiFi)

- basic knowledge on handling personal computer and the internet

- owning a smartphone with the operating system Android or IOS and with access to Google Play Store or Apple App score

- ability to read, write and comprehend as well as communicate electronically

- not regularly physically active (more than 30 minutes twice a week with a moderate intensity (includes aerobic training, resistance training and other sports e.g. Tennis; excludes physiotherapy, physical activity during work or household, grocery shopping, gardening, walking the dog etc.)

Exclusion Criteria:

- clinically relevant cardiovascular diseases

- cortisone therapy in the last 30 days

- cognitive impairment

- severe impairment of hand function (ataxia or paresis impeding the use of a smartphone app or smartwatch)

- severe internal, orthopaedic and metabolic diseases that restrict mobility

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity counseling
Physical activity counseling consists of two phone or video calls with a therapists, two group video calls with a therapist and a complementary e-learning course.
Exercise
Participants will agree with their therapist on an exercise plan (endurance and resistance training) that will be made available through the studies mobile app. Frequency and duration of endurance and strength training shall be prescribed in accordance with exercise guidelines for pwMS. However, they can be adjusted according to participants prior physical activity level and their available time slots for exercise during the week.

Locations

Country Name City State
Germany Neurological Rehabilitation Center Quellenhof Bad Wildbad Baden-Wuerttemberg
Germany Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) Erlangen
Germany Klinikum Würzburg Mitte gGmbH Würzburg Bavaria

Sponsors (8)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Aktion Multiple Sklerose Erkrankter, Landesverband der DMSG in Baden-Württemberg (AMSEL) e.V., Center for Telemedicine Bad Kissingen (ZTM), Klinikum Würzburg Mitte GmbH, Medi train - Zentrum für Gesundheitssport, Sport- und Physiotherapie, motionNET systems Limited, Neurological Rehabilitation Center Quellenhof, proMX GmbH Nürnberg

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acceptability of the Intervention and participants' experiences (focus groups) Focus groups (1,5 hrs) with participants to determine extent to which they perceived intervention as appropriate. 1 week after the end of the intervention
Primary Compliance with intervention protocol (completed training sessions and e-learning modules) Completed training sessions and e-learning modules will be documented for each participant with the interventions mobile app and e-learning course. over the 12 weeks of intervention
Primary Acceptability of the Intervention and participants' experiences (interviews) With those participants that cannot take part in the focus groups, semistructured interviews (30 min) will be conducted to determine extent to which participants' perceived intervention as appropriate. Interview questions are based on focus group questions. The wording is slightly adapted to fit the interview situation. 1 week after the end of the intervention
Secondary Changes in objectively measures physical activity The physical activity level of participants is measured over a 7 day period with the accelerometer Actigraph GT3X+. The Actigraph GT3X+ measures acceleration on three axes. Steps per day, physical activity per day (activity counts) and time in moderate and vigorous physical activity per day will be calculated. 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
Secondary Changes in subjectively measured physical activity: European Health Interview Survey-Physical Activity Questionnaire (EHIS-PAQ) 8-item questionnaire to assess time spent for work related physical activity, physical activity for transportation (walking, biking), muscle strengthening exercises and sports, fitness or recreational physical activity during a typical week. 1 week before start of the intervention (T0), 1 week after end of the intervention (T1)
Secondary Würzburger Fatigue Inventory for MS (WEIMuS) This questionnaire contains 17 items that form a physical and cognitive subscale. The total score ranges from zero to a maximum of 68 points (maximum fatigue). The cut-off value for the presence of fatigue is above 32. 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
Secondary Allgemeine Depressionsskala (ADS-L) German version of the Center for Epidemiologic Studies Depression Scale, 20 item questionnaire. Each item is rated on a 4-point Likert scale. Answers are scored from 0 to 3. The scores for all items are added up to receive the total score. The total score ranges from 0 to 60 with higher scores representing higher levels of depression. 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
Secondary Multiple Sclerosis Walking Scale-12 12-item questionnaire measuring self reported walking ability. Each item is answered on a 5-point Likert scale. Answers are scored from 1 to 5. The scores for all items are added up to receive a total score. The total score ranges from 12 to 60 with higher scores representing higher levels of depression. As a last step the total score is transformed into the walk12-score ranging from 0 to 100 ((total score -12)/48 x 100 = walk12-score). 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis